| Literature DB >> 22586351 |
Abstract
Ying and colleagues identify a novel function of Pten as a haploinsufficient tumor suppressor in human pancreatic cancer development. Genomic, genetic, and biochemical data reveal that Pten loss and Kras mutation cooperate to accelerate pancreatic cancer development by altering PI3K regulation to enhance NF-κB activation and upregulate downstream cytokine genes; this provides a protumorigenic and metastatic microenvironment.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22586351 DOI: 10.1158/2159-8290.CD-11-0115
Source DB: PubMed Journal: Cancer Discov ISSN: 2159-8274 Impact factor: 39.397